Hexagon Capital Partners LLC Verona Pharma PLC Put Options Transaction History
Hexagon Capital Partners LLC
- $508 Million
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding VRNA
# of Institutions
150Shares Held
66.3MCall Options Held
495KPut Options Held
486K-
Ra Capital Management, L.P. Boston, MA7.63MShares$298 Million1.66% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$218 Million7.62% of portfolio
-
Deep Track Capital, LP Greenwich, CT4MShares$156 Million1.9% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$138 Million14.95% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.31MShares$129 Million2.82% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $2.38B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...